Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

10454

Cytomegalovirus Infection And Neurovascular Damage In The Bordeaux-3C Cohort

Part of Topic

Introduction:

∙CMV infection is frequent and may contribute to vascular damages

∙Findings of studies on CMV infection and  cerebrovascular diseases such as stroke or vascular dementia (VD) remains inconsistent

∙Few studies have examined early neuroimaging markers of vascular damages or the potential modifying roles of factors such as age, neuroinflammation, and APOE4 status

 

Objective:

Assess the association between CMV infection and both neuroimaging markers of vascular damage and the occurrence of stroke or VD taking into account factors could modify this association (age, neuroinflammation (via plasma glial fibrillary acidic protein (GFAP) levels) and APOE4)

Statistical models: adjusted multiple linear regressions or Cox models in 3C-Bordeaux cohort
 
Results:

In the larger study sample (N=1156 for VD) with a mean age of 74 years; 63% were women, 67% were CMV-seropositive, and 19% were APOE4 carriers.

During follow-up, 44 participants developed stroke and 31 developed VD.   

CMV infection and neuroimaging markers of vascular damages:

→ Greater number of ePVS-clusters in the basal ganglia in CMV-infected participants

→ Significant interactions only with GFAP level for ePVS in basal ganglia and total WMH volume at 10 year

→↗ neurodamages only in CMV-infected participants with higher GFAP level
 

CMV infection and risk of stroke or VD:

→Trend toward an increased risk of stroke in CMV-infected participants (P = 0.08)
→No significant interaction with age, APOE4 status or GFAP levels
 
Conclusion:

We combined diagnoses of cerebrovascular disease with neuroimaging vascular markers to better characterize brain vascular health in our study. Our results showed greater neurovascular damage in CMV-infected subjects compared to non-infected ones, particularly among participants with higher levels of GFAP. Further analyses are underway to examine and understand the role of neuroinflammation in CMV effects.

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.